ASIA News
During April, we'll talk to experts and thought leaders about what's really happening in interoperability, present original HIMSS Media research on the state of data exchange, delve into the newly proposed rule from HHS and share insights about what the future holds.
China Maternal and Child Health Care Association and Wuhan University Landing AI Cytology Diagnostic Centre recently launched a cervical cancer screening AI cloud diagnostic platform.
AIA, the largest public listed pan-Asian life insurance group, and Singtel, the largest mobile network operator in Singapore, yesterday announced a partnership to promote consumer wellness.
Founded by CEO Raghu Rai and serial entrepreneur Ken Rohl in 2014, Vietnam-based health tech startup Jio Health recently announced that it has raised $5M series A funding led by VC fund Monk Hill’s Ventures.
Last week, ECRI Institute, a nonprofit that focuses on healthcare quality, announced that it will be launching its first medical device evaluation laboratory outside the US.
NTUC Income, a Singapore-based insurance cooperative and DaVita, a US-based company which provides kidney dialysis across the US and in 9 countries worldwide, recently announced a joint venture (JV), DaVita Singapore, to operate kidney dialysis centres in Singapore.
Biolinq's new funding was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.
Ibex Medical Analytics, an Israel-based startup founded in 2016 which is developing their own AI-driven computational pathology cancer diagnosis system, recently completed an $11M Series A funding round led by aMoon Fund.
ConnectedLife partners with Ocean Protocol to advance diagnosis and treatment of Parkinson’s disease
Singapore-headquartered health AI company ConnectedLife today announced its partnership with Singapore-based non-profit foundation Ocean Protocol to advance the diagnosis and treatment of Parkinson's disease with a safe method of sharing patient-generated data.
Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC.